top of page
Screenshot 2024-02-17 at 12.56.02 PM.png
male-business-executive-giving-speech-2-1 (2).jpg

Course Material 


As advancements in systemic therapy continue to improve survival of patients with metastatic cancer, the frequency of patients requiring radiation therapy for treatment of brain metastases has increased. Radiotherapeutic management of brain metastases can range from radiosurgery to whole brain radiation with or without hippocampal sparing. What are some of the considerations in selecting patients for stereotactic radiotherapy, and what dose fractionations should we use? How should we approach and contour leptomeningeal disease, skull metastases and the hippocampus? How do we differentiate post-treatment radiation changes from disease progression on surveillance imaging?

Join us for this session as we learn from our panel of international and local experts about the management of brain metastases.

About us

RadoncAsia is a medical conference dedicated to advancing Radiation Oncology excellence in Asia. Working with Asian institutions, Read More …

Contact us

The School of Clinical Oncology


Sign up for the latest news, updates, and more from RadoncAsia. 

bottom of page